Your browser doesn't support javascript.
loading
HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.
Lu, Hongjian; Zhang, Ronghua; Zhang, Shukun; Li, Yufeng; Liu, Yankun; Xiong, Yanan; Yu, Xiaohan; Lan, Tao; Li, Xin; Wang, Meimei; Liu, Zhiyong; Zhang, Guangling; Li, Jingwu; Chen, Shuang.
Afiliación
  • Lu H; North China University of Science and Technology Affiliated Hospital, School of Public Health, North China University of Science and Technology, Tangshan 063210, China.
  • Zhang R; North China University of Science and Technology Affiliated Hospital, School of Public Health, North China University of Science and Technology, Tangshan 063210, China.
  • Zhang S; Institute of Acute Abdominal Diseases of Integrated Traditional Chinese and Western Medicine, Tianjin Nankai Hospital, Nankai Clinical College, Tianjin Medical University, Tianjin 300100, China.
  • Li Y; The Cancer Institute, Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, Tangshan 063001, China.
  • Liu Y; The Cancer Institute, Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, Tangshan 063001, China.
  • Xiong Y; North China University of Science and Technology Affiliated Hospital, School of Public Health, North China University of Science and Technology, Tangshan 063210, China.
  • Yu X; North China University of Science and Technology Affiliated Hospital, School of Public Health, Hebei Provincial Key Laboratory of Medical-Industrial Integration Precision Medicine, North China University of Science and Technology, Tangshan 063000, China.
  • Lan T; Hepatobiliary Pancreatic Surgery Department, Cangzhou People's Hospital, Cangzhou 061000, China.
  • Li X; Hepatobiliary Pancreatic Surgery Department, Cangzhou People's Hospital, Cangzhou 061000, China.
  • Wang M; North China University of Science and Technology Affiliated Hospital, School of Public Health, North China University of Science and Technology, Tangshan 063210, China.
  • Liu Z; Health Science Center, North China University of Science and Technology, Tangshan 063210, China.
  • Zhang G; North China University of Science and Technology Affiliated Hospital, School of Public Health, Hebei Provincial Key Laboratory of Medical-Industrial Integration Precision Medicine, North China University of Science and Technology, Tangshan 063000, China. Electronic address: zhanggl@ncst.edu.cn.
  • Li J; The Cancer Institute, Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, Tangshan 063001, China. Electronic address: tslijingwu@163.com.
  • Chen S; Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin 300450, China. Electronic address: shuang7332@163.com.
Int Immunopharmacol ; 124(Pt B): 111002, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37804655
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs Límite: Animals Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs Límite: Animals Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos